Health In Tech (HIT) Insider Grant: 27,000 Restricted Class A Shares to CFO

Rhea-AI Filing Summary

Health In Tech, Inc. (HIT) reporting person LinLin Qian, who serves as Chief Financial Officer, Director and a reported 10% owner, received a grant of 27,000 restricted shares of Class A Common Stock on 08/15/2025. The restricted shares were issued under the Health in Tech Equity Incentive Plan and vest based on operational milestones: 50% vest monthly over 12 months after the first specified program is launched and operational, and the remaining 50% vest monthly over 12 months after the second specified program is launched and operational. Following the transaction the reporting person beneficially owns 8,048,555 shares (which the filing states include 55,193 restricted shares and 7,993,362 Class A shares), while the filing excludes certain Class B shares and options.

Positive

• 27,000 restricted Class A shares granted to the CFO/Director, aligning pay with company operational milestones
• Vesting is milestone-based (two product launches), which ties value realization to execution rather than time-only vesting
• Reporting person retains significant ownership with 8,048,555 beneficially owned shares, indicating management stake

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Insider CFO received milestone-based restricted stock, aligning executive incentives with product launches while modestly increasing reported ownership.

The grant of 27,000 restricted Class A shares ties management compensation to the operational launch of two specified programs, which strengthens alignment between executive incentives and company milestones. Vesting is milestone-linked rather than time-only, which may reduce gratuitous near-term dilution and focuses value delivery on execution. The reporting person remains a substantial holder with 8,048,555 beneficially owned shares, improving perceived management skin in the game. The filing excludes Class B shares and outstanding options, so total economic exposure is larger than Class A counts alone.

Securities Analyst

TL;DR: The transaction is a routine, non-cash equity grant that is execution-contingent and unlikely to materially affect near-term cap structure.

The 27,000-share award at $0 price indicates restricted shares issued as compensation rather than market purchases. Because vesting depends on successful launches, immediate dilution is limited to recorded outstanding shares; the filing shows 55,193 restricted shares included in beneficial ownership. Investors should note that additional instruments (2,700,000 Class B shares and 711,510 options) are excluded from the Class A total in this report, so full potential dilution requires reviewing other filings. Overall, this Form 4 documents governance-aligned compensation rather than capital-market activity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Qian LinLin

(Last) (First) (Middle)

701 S. COLORADO AVE,

SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/15/2025		A		27,000(1)	A	$0	8,048,555(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Fifty percent (50%) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of two specified programs being developed by the Company is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other specified program being developed by the Company is successfully launched and fully operational in the marketplace.

2. Includes 55,193 shares of restricted stock and 7,993,362 shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

	/s/ LinLin Qian	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LinLin Qian report on Form 4 for HIT?

The filing reports a grant of 27,000 restricted Class A Common Stock shares to LinLin Qian on 08/15/2025 under the company equity incentive plan.

How do the restricted shares vest according to the Form 4?

Vesting is milestone-based: 50% vests monthly over 12 months after the first specified program is launched and operational; the remaining 50% vests monthly over 12 months after the second specified program is launched and operational.

How many shares does the reporting person beneficially own after the transaction?

The filing states the reporting person beneficially owns 8,048,555 shares, which includes 55,193 restricted shares and 7,993,362 Class A shares.

Were any shares sold or purchased for cash in this transaction?

No; the transaction code is an A (acquisition) of restricted shares with a reported price of $0, indicating a compensation grant rather than a market purchase.

Does the Form 4 disclose other securities not included in the Class A total?

Yes; the filing explicitly excludes 2,700,000 Class B shares and 711,510 options from the Class A beneficial ownership total.